Wednesday, April 1, 2026
25 C
Bengaluru

Managed Healthcare – Better Choice for India?

Managed care shifts healthcare from fragmented fee-for-service models to coordinated, prevention-focused systems, delivering better outcomes and cost control. Proven internationally and emerging in India via Even Healthcare and PM-JAY pilots, it promises value-based care amid rising expenses. For MedicinMan readers in pharma and policy, this unified approach aligns with Ayushman Bharat’s evolution. ncbi.nlm.nih+1​​

Fee-for-Service Flaws

Traditional fee-for-service (FFS) bills per procedure, incentivizing volume over quality and fragmenting care across uncoordinated providers. Patients enjoy doctor choice without referrals, but this leads to redundant tests, over-treatment, and soaring costs—over 60% out-of-pocket in India’s private sector. macpac+2

Managed Care Core

Managed care integrates delivery and financing through provider networks, with primary care physicians (PCPs) as gatekeepers for referrals, emphasizing prevention via wellness programs and care coordination. Tools like pre-authorization, formularies, and reviews ensure right care at right cost, with fixed copays for predictability. editorsweb+2

Global Success Stories

US Medicaid managed care cuts readmissions for chronic conditions like diabetes and boosts preventive screenings. Switzerland’s models sustain 10-year cost savings and lower mortality versus FFS. Payer-led systems excel in diabetes management and cancer detection. macpac+2

Indian Breakthroughs

Even Healthcare in Bengaluru achieves 2.58% readmissions (vs. 8-12% national), zero unplanned returns in 350+ surgeries, 40% shorter stays, 200+ avoided hospitalizations, and 6X ROI. PM-JAY covers 500M with Rs. 5 lakh/family cashless care via empaneled networks and 150,000 wellness centers. economictimes.indiatimes+4

State Pilots Excel

Karnataka (Even): Subscription model yields superior metrics for corporates.economictimes.indiatimes
Tamil Nadu (UHC Pilot): 2016-2018 blocks cut OOPE, diverted patients to public care, lowered per-visit costs.nhm.tn+1
Chhattisgarh (PM-JAY): Top performer with 97% active hospitals, fast claims.economictimes+1
Kerala’s KASP blends elements for high enrollment. keralacalling.kerala

Key Challenges

Financial hurdles like low PM-JAY rates and delays deter providers. Infrastructure gaps, rural disparities, and HR shortages persist. Awareness deficits cause exclusions; regulations lack MCO standards. csep+6

ChallengeImpactExample
Low Rates/DelaysProvider DropoutPM-JAY Budget Underuse csep
Fragmented DataPoor CoordinationRural Enrollment Errors ijrti
Regulatory GapsLow ScalabilityNo National MCO Framework drishtiias

Path to Scale

Managed care enhances outcomes like HbA1c reductions and satisfaction, countering FFS excesses. Pharma can drive via outcome-linked innovations and PM-JAY compliance. Digital upgrades, incentives, and unified protocols will unlock equity. healthcareexecutive+4

Appendix: Sources

  1. https://www.ncbi.nlm.nih.gov/books/NBK564410/
  2. https://health.economictimes.indiatimes.com/news/industry/even-healthcare-data-suggests-managed-care-is-the-model-india-needs/126183783
  3. https://www.caplinehealthcaremanagement.com/what-is-the-difference-between-fee-for-service-and-managed-care/
  4. https://www.macpac.gov/medicaid-101/provider-payment-and-delivery-systems/
  5. https://www.healthcareexecutive.in/blog/even-healthcare
  6. https://www.editorsweb.org/health-care/traditional-vs-managed-care.htm
  7. https://www.macpac.gov/subtopic/managed-cares-effect-on-outcomes/
  8. https://onlinelibrary.wiley.com/doi/10.1002/hec.3392
  9. https://www.mckinsey.com/industries/healthcare/our-insights/innovation-and-value-what-payer-led-managed-care-models-may-look-like
  10. https://www.mediainfoline.com/health/even-healthcare-releases-data-on-managed-cares-effectiveness-in-safer-recovery-and-reduced-hospitalisations
  11. https://nha.gov.in/PM-JAY
  12. https://pmc.ncbi.nlm.nih.gov/articles/PMC7747303/
  13. https://www.nhm.tn.gov.in/sites/default/files/2019-10/UHC%20Pilot%20Report_Tamilnadu_IITM_24Feb2018.pdf
  14. https://hss.iitm.ac.in/ctap/wp-content/uploads/2022/05/UHC-Pilot-Report-Tamilnadu-IITM.pdf
  15. https://economictimes.com/news/india/chhattisgarh-adjudged-best-performing-state-under-pradhan-mantri-jan-arogya-yojana/articleshow/124605313.cms
  16. https://static.pib.gov.in/WriteReadData/specificdocs/documents/2023/aug/doc202382232101.pdf
  17. https://keralacalling.kerala.gov.in/ensuring-health-for-all-keralas-inclusive-healthcare-model/
  18. https://csep.org/working-paper/opportunities-and-challenges-in-health-financing-in-india/
  19. https://www.sciencedirect.com/science/article/pii/S2213398421000038
  20. https://pmc.ncbi.nlm.nih.gov/articles/PMC10573738/
  21. https://www.ndtv.com/health/doctor-shares-the-top-healthcare-challenges-india-must-solve-in-2026-before-the-costs-become-unmanageable-9797256
  22. https://www.drishtiias.com/daily-updates/daily-news-analysis/managed-care-organisations
  23. https://www.ijrti.org/papers/IJRTI2507148.pdf
  24. https://www.policycircle.org/policy/challenges-facing-ayushman-bharat/
  25. https://dvararesearch.com/managed-care-linking-health-care-with-health-insurance/

All Images are AI Generated for Illustration Only. E&OE

Hot this week

FieldForce Is Not Your Frontline Anymore. Meet the New Force in Healthcare

When drones first appeared on battlefields, military establishments reacted...

Razumab at 11: A Decade of Disruption, Safety Lessons, and the New Biosimilar Reality

Abstract When Intas Pharmaceuticals launched Razumab in June 2015 as...

Healthcare and Gulf War: When Elephants Fight, the Grass Gets Trampled

From Gas Cylinders to ICU Beds: How the Gulf...

Semaglutide: Just Another Off-Patent Generic? Or a Different Beast Entirely?

As over 50 generic versions of the blockbuster weight-loss...

Excellence or Mediocrity—What Are You Building?

Excellence is a choice. So is Mediocrity Excellence is a...

Topics

FieldForce Is Not Your Frontline Anymore. Meet the New Force in Healthcare

When drones first appeared on battlefields, military establishments reacted...

Razumab at 11: A Decade of Disruption, Safety Lessons, and the New Biosimilar Reality

Abstract When Intas Pharmaceuticals launched Razumab in June 2015 as...

Semaglutide: Just Another Off-Patent Generic? Or a Different Beast Entirely?

As over 50 generic versions of the blockbuster weight-loss...

Excellence or Mediocrity—What Are You Building?

Excellence is a choice. So is Mediocrity Excellence is a...

Gila Monster Venom: The Unexpected Spark of the GLP-1 Revolution

In the blistering Sonoran Desert, where temperatures regularly exceed...

The Quiet Crisis in the Indian Pharma Field Force

A MedicinMan Editorial based on the Poll framed by...
spot_img

Related Articles

spot_imgspot_img